Please wait while the transcript is being prepared...
0:00
This presentation will examine
regulatory affairs in Pharma,
with a focus on the role
of regulatory affairs in
guiding pharmaceutical
products from
development through
approval and beyond,
by ensuring compliance with
global and regional
requirements.
We will discuss the
preparation and
submission of regulatory
documentation,
the importance of early
engagement with agencies,
and the need for robust
coordination across functions.
Key topics include the global
nature of drug development,
adherence to
international guidelines,
and the critical role
of documentation and
strategy throughout the
product life cycle.
Finally, we will highlight how
regulatory affairs
drives ethical,
transparent, and efficient
drug development
while maintaining public
trust and safety.
Regulatory affairs bridges
science, business,
and law to bring safe,
effective medicines to patients.
It ensures compliance with
regulations at every stage,
from development through
approval and beyond.
The role includes interpreting
global regulations,
designing market strategies for
legal frameworks like the FDA,
EMA and MHRA, and
ensuring communication between
companies and agencies.
A key responsibility in
regulatory affairs is preparing,
coordinating and submitting
documentation for agency review,
a critical process for gaining
clinical trial approval and
eventually marketing
authorization.
Submissions must be robust,
accurate and tailored to
regional requirements,
such as the US IND
or EU CTA IMPD.
